Literature DB >> 7710939

Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid.

W G Jiang1, S Hiscox, M B Hallett, C Scott, D F Horrobin, M C Puntis.   

Abstract

In this study we have determined the effects of the n-6 essential fatty acid gamma-linolenic acid (GLA) on the motility and invasive/metastatic nature of the human colon cancer cell lines HT115, HT29 and HRT18. Cell motility was induced by hepatocyte growth factor/scatter factor (HGF/SF) and measured by both colony scattering and dissociation from carrier beads. Invasiveness was measured in vitro by cellular invasion into extracellular matrix. At concentrations up to 100 microM (which had no effect on cell growth over the duration of the experiments) both cell motility and invasion induced by HGF/SF were markedly reduced by GLA and its lithium salt. The attachment of these cells to the extracellular matrix components (Matrigel and fibronectin) was also inhibited. There were also changes in the cell-surface E-cadherin, but not fibronectin receptor at similar concentrations. It is concluded that n-6 essential fatty acids have the ability to inhibit both motility and invasiveness of human colon cancer cells, perhaps by modifying cell-surface adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710939      PMCID: PMC2033731          DOI: 10.1038/bjc.1995.145

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Authors:  A Albini; Y Iwamoto; H K Kleinman; G R Martin; S A Aaronson; J M Kozlowski; R N McEwan
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

2.  Controlled trial of gamma linolenic acid in Duke's C colorectal cancer.

Authors:  M B McIllmurray; W Turkie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

Review 3.  Management of cancer of the colon.

Authors:  G A Donaldson; J P Welch
Journal:  Surg Clin North Am       Date:  1974-06       Impact factor: 2.741

4.  Oral gamma-linolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open clinical trial.

Authors:  C F Van der Merwe; J Booyens; I E Katzeff
Journal:  Br J Clin Pract       Date:  1987-09

5.  Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation.

Authors:  M E Bégin; G Ells; D F Horrobin
Journal:  J Natl Cancer Inst       Date:  1988-04-06       Impact factor: 13.506

6.  Biochemical mechanisms of tumor invasion and metastases.

Authors:  L A Liotta
Journal:  Clin Physiol Biochem       Date:  1987

7.  Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids.

Authors:  M E Bégin; G Ells; U N Das; D F Horrobin
Journal:  J Natl Cancer Inst       Date:  1986-11       Impact factor: 13.506

8.  An improved colorimetric assay for interleukin 2.

Authors:  H Tada; O Shiho; K Kuroshima; M Koyama; K Tsukamoto
Journal:  J Immunol Methods       Date:  1986-11-06       Impact factor: 2.303

Review 9.  Clinical perspective of human colorectal cancer metastasis.

Authors:  D A August; R T Ottow; P H Sugarbaker
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo.

Authors:  H J Hussey; M J Tisdale
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more
  20 in total

1.  Claudin-5 participates in the regulation of endothelial cell motility.

Authors:  Astrid Escudero-Esparza; Wen G Jiang; Tracey A Martin
Journal:  Mol Cell Biochem       Date:  2011-10-26       Impact factor: 3.396

2.  Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids.

Authors:  W G Jiang; S K Singhrao; S Hiscox; M B Hallett; R P Bryce; D F Horrobin; M C Puntis; R E Mansel
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

3.  Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration.

Authors:  Andrew J Sanders; David G Jiang; Wen G Jiang; Keith G Harding; Girish K Patel
Journal:  Int Wound J       Date:  2011-08-04       Impact factor: 3.315

4.  Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Authors:  Siobhan L Webb; Andrew J Sanders; Malcolm D Mason; Wen G Jiang
Journal:  Mol Cell Biochem       Date:  2012-12-13       Impact factor: 3.396

5.  α-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells.

Authors:  María José González-Fernández; Ignacio Ortea; José Luis Guil-Guerrero
Journal:  Toxicol Res (Camb)       Date:  2020-07-27       Impact factor: 3.524

6.  Lysine 63-linked ubiquitination is important for arachidonic acid-induced cellular adhesion and migration.

Authors:  Denise M Ray; Brian A Rogers; Jeffrey A Sunman; Steven K Akiyama; Kenneth Olden; John D Roberts
Journal:  Biochem Cell Biol       Date:  2010-12       Impact factor: 3.626

7.  Inhibition of cancer cell motility and invasion by interleukin-12.

Authors:  S Hiscox; M B Hallett; M C Puntis; W G Jiang
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  IL-17B Can Impact on Endothelial Cellular Traits Linked to Tumour Angiogenesis.

Authors:  Andrew J Sanders; Xiaoxia Guo; Malcolm D Mason; Wen G Jiang
Journal:  J Oncol       Date:  2010-05-06       Impact factor: 4.375

9.  Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.

Authors:  Astrid Escudero-Esparza; Wen G Jiang; Tracey A Martin
Journal:  J Exp Clin Cancer Res       Date:  2012-05-04

10.  The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.

Authors:  Mu Hu; Lin Ye; Fiona Ruge; Xiuyi Zhi; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2012-12-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.